Citi Pharma Ltd (CITI)

Currency in PKR
74.81
-0.27(-0.36%)
Closed·
High dividend Yield
CITI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
74.6375.75
52 wk Range
69.25104.25
Key Statistics
Bid/Ask
74.81 / 74.81
Prev. Close
75.08
Open
75
Day's Range
74.63-75.75
52 wk Range
69.25-104.25
Volume
329.77K
Average Volume (3m)
1.83M
1-Year Change
-11.6243%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CITI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.00

Earnings

Latest Release
03/06/2026
EPS / Forecast
1.21 / --
Revenue / Forecast
3.08B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.80%
Dividend Yield
4.66%
Industry Median 4.06%
Annualised payout
3.50
Paid annually
5-Years Growth
-
Growth Streak

Compare CITI to Peers and Sector

Metrics to compare
CITI
Peers
Sector
Relationship
P/E Ratio
15.6x16.1x−0.4x
PEG Ratio
0.490.370.00
Price/Book
1.6x3.2x2.6x
Price / LTM Sales
1.2x1.5x3.1x
Upside (Analyst Target)
-16.6%50.8%
Fair Value Upside
Unlock25.1%7.8%Unlock

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Its product portfolio includes capsules, tablet, syrup drops, ointment, sachet, and formulation. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan.

Employees
531
Market
Pakistan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.58M2.00%342.34M
Other Institutional Investors
11.77M5.15%880.22M
Public Companies & Retail Investors
212.12M92.85%15.87B
Total
228.46M100.00%17.09B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Alfalah Asset Management Ltd.1.50%3,426,107256,273
National Clearing Company of Pakistan Limited1.06%2,422,277181,186

People Also Watch

195.87
AGPL
-1.58%
20.79
POWE
-2.21%
388.42
NATF
-1.45%
38.81
GHGL
-1.27%

FAQ

What Is the Citi Pharma (Karachi: CITI) Share Price Today?

The Citi Pharma stock price today is 74.81 PKR.

What Stock Exchange Does Citi Pharma (CITI) Trade On?

Citi Pharma is listed and trades on the Karachi Stock Exchange.

What Is the Ticker (Stock Symbol) for Citi Pharma?

The stock symbol (also called a 'ticker') for Citi Pharma is "CITI."

Does Citi Pharma Pay Dividends? What’s The Current CITI Dividend Yield?

Yes, CITI Pays Dividends to its Shareholders. The current Citi Pharma dividend yield is 4.68%.

What Is the Current Citi Pharma Market Capitalisation?

As of today, Citi Pharma (Karachi: CITI) market cap is 17.15B PKR.

What Is Citi Pharma's (CITI) Earnings Per Share (TTM)?

The Citi Pharma EPS is currently 4.80 (Trailing Twelve Months).

When Is the Next Citi Pharma Earnings Date?

Citi Pharma's next earnings report will be released on 02/09/2026.

Is CITI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Citi Pharma moving averages and other technical indicators, the daily buy/sell signal for CITI stock is Strong Sell.

How Many Times Has Citi Pharma Stock Split?

Citi Pharma has split 1 times. (See the CITI stock split history page for full effective split date and price information.)

How Many Employees Does Citi Pharma Have?

Citi Pharma has 531 employees, based on their latest Companies House report.

What is the current trading status of Citi Pharma (Karachi: CITI)?

As of 17/07/2026, Citi Pharma (CITI) is trading at a share price of 74.81 PKR, with a previous close of 75.08 PKR. The stock has fluctuated within a day range of 74.63 PKR to 75.75 PKR, while its 52-week range spans from 69.25 PKR to 104.25 PKR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.